期刊文献+

脓毒症液体治疗争论与进展 被引量:9

Argument and progress of fluid therapy for sepsis
原文传递
导出
摘要 重症脓毒症是指合并脏器功能障碍的细菌感染。造成循环功能和细胞代谢功能障碍的感染则为脓毒性休克。脓毒症早期紧急治疗的重要性如同脑卒中和心肌梗死的治疗。早期诊断脓毒症并及时开展合理的治疗可显著降低病死率。脓毒症的液体治疗包括初始复苏和后续的液体治疗,并可分为抢救、改善、稳定和去复苏4个阶段。复苏的初期阶段也被称为黄金6h。在第1个3h阶段,主要选用晶体液进行复苏,可按30mL/kg体重,大约2000 mL晶体液给予。"1h集束治疗"强调,液体复苏的量不一定要在1h内完成,但必须在1h内启动。后续的液体治疗要在连续监测症状体征的同时结合血液动力学监测决定后续补液速度与补液量。只有在感染源得到控制后才能达到有效的去复苏。 Sepsis is the organ dysfunction caused by infection.Septic shock is a subset of sepsis with circulatory and cellular/metabolic dysfunction.Early immediate diagnosis and treatment of sepsis is as important as the early intervention of acute myocardial infarction and stroke,which can significantly reduce mortality.The fluid therapy for sepsis includes early resuscitation and subsequent fluid therapy and can be divided into four phases involving the resuscitation phase,the optimization phase,the stabilization phase and the de-resuscitation phase.The first 6 hours of the early resuscitation of sepsis are called"golden 6 hours".At the first3 hours period,approximately 2 milliliter crystal fluid calculated from 30 mL/kg should be given.The resuscitation should be launched within the first 1 hour,although it does not need to be finished within the first 1 hour.Subsequent fluid therapy should be guided by sequential assessment of clinical symptoms and signs combined with monitoring of hemodynamic examinations.De-resuscitation could be realized only after appropriate source control.
作者 任建安 REN Jian-an(Research Institute of General Surgery,General Hospital of Eastern Military Command of PIA,Nanjing 210002,China)
出处 《中国实用外科杂志》 CSCD 北大核心 2020年第1期33-36,共4页 Chinese Journal of Practical Surgery
基金 江苏省重点研发社会发展项目-重点病种规范化诊疗项目(No.BE2016752) 解放军军事医学创新工程(No.16CXZ007)
关键词 脓毒症 脓毒性休克 战胜脓毒症运动 液体疗法 复苏 sepsis septic shock surviving sepsis campaign fluid therapy resuscitation
  • 相关文献

参考文献4

二级参考文献16

  • 1Riedemann NC, Guo RF, Ward PA. The enigma of sepsis [ J ]. J Clin Invest, 2003,112 ( 4 ) :460 - 467.
  • 2Dellinger RP,Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Intensive Care Med, 2008,36 ( 1 ) : 296 - 327.
  • 3Schrier RW, Wang W. Acute renal failure and sepsis [ J ]. N Engl J Med,2004,351 (2) :159-169,
  • 4Le Blanc L, Lesur O, Valiquette L, St-Pierre C. Role of routine blood cuhures in detccling unapparent infections during continuous renal replacement therapy[J]. Intensive Care Med,2006,32 (11) :1802 -1807.
  • 5Ronco C, Bellomo R, Lonneman G. Sepsis-theory and therapies [J]. N Engl J Med,2003,348(16) :1600 -1602.
  • 6低血容量休克复苏指南(2007)[J].中国实用外科杂志,2007,27(8):581-587. 被引量:234
  • 7Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Cam- paign: international guidelines for management of severe sepsis and septic shock: 2008 [J ]. Crit Care Med, 2008,36(1): 296-327.
  • 8Lush CW, Kvie/ys PR. Microvascular dysfunction in sepsis [J]. Microcirculation, 2000,7(2):83 - 101.
  • 9Raghavan M, Marik PE. Management of sepsis during the early "golden hours"[J]. J Emerg Med, 2006, 31 (2): 185-199.
  • 10Morimatsu H, Singh K, Uchino S, et al. Early and exclusive use of norepinephrine in septic shock [J]. Resuscitation, 2004, 62 ( 2 ): 249-254.

共引文献54

同被引文献103

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部